Our work is a critical part of the vaccine development pipeline. Our efforts ensure that only the most promising vaccine candidates are moved through to trials on humans.
We're working on the development, testing and manufacture of a vaccine for the novel coronavirus responsible for causing COVID-19.
Our researchers have confirmed the now-dominant G-strain of the SARS-CoV-2 virus should not adversely affect vaccine candidates in development.
We worked with vaccine developers to produce small volumes of candidate vaccines to the highest quality standards, for use in trials. If successful, our manufacturing process can be scaled with an industry partner.
Our preclinical trials of leading vaccine candidates are supporting the global race against the pandemic to find a safe and effective COVID-19 vaccine.
We are working with the research sector and industry on the preclinical evaluation of potential antiviral drugs, to see if they are effective against COVID-19.
Enter a valid email address, for example jane.doe@csiro.au.
First name must be filled in
Surname must be filled in
We'll need to know what you want to contact us about so we can give you an answer.
For security reasons attachments are not accepted.
Sorry, an error has occured, please try again.
We have received your enquiry and will reply soon.
